Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models
Pharmaceutics · 07.02.2025 · 17 (2) · 214
DOI: 10.3390/pharmaceutics17020214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 07.02.2025. Verfasst von Jing Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Drug Metabolism and Pharmacokinetics, School of pharmacy, China Pharmaceutical University, Nanjing 210009, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Public Security, Open Project of the Key Laboratory of Drug Monitoring and Control, Ministry of Public Security, China.
Abstract (Originalsprache)
Background/Objectives: The use of medicines in pediatrics and geriatrics is widespread. However, information on pharmacokinetics of therapeutic drugs mainly comes from healthy adults, and the pharmacokinetic parameters of therapeutic drugs in other age stages, including pediatrics and geriatrics, are limited. The aim of the study was to develop a dynamic age-dependent physiologically based pharmacokinetic (PBPK) model to predict the pharmacokinetics of drugs in humans at different ages.
Method
The PBPK models characterizing dynamic age-dependence were developed in adults (20–59 years old) and 1000 virtual individuals were constructed. Four CYP3A substrates, namely midazolam, fentanyl, alfentanil and sufentanil, served as model drugs. Following validation using clinic observations in adult populations, the developed PBPK models were extrapolated to other age populations, such as pediatrics and geriatrics, via replacing their physiological parameters and pharmacokinetic parameters, such as organ volume, organ blood flow, clearance, fu,b and Kt:p. The simulations were compared with clinic observations in corresponding age populations. Midazolam served as an example, the dose transitions between adult pediatrics and adult geriatrics were visualized using the developed PBPK models.
Results
Most of observed plasma concentrations fell within the 5th–95th percentile of the predicted values in the 1000 virtual individuals, and the predicted AUC0–t and Cmax were almost within between 0.5 and 2 times of the observations. The optimization of dosages in pediatrics and geriatrics were further documented.
Conclusions
The developed PBPK model may be successfully used to predict the pharmacokinetics of CYP3A4-metabolized drugs in different age groups and to optimize their dosage regiments in pediatrics and geriatrics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Drug Metabolism and Pharmacokinetics, School of pharmacy, China Pharmaceutical University, Nanjing 210009, China.
ORCID-Profile: Zexin Zhang, Xiaodong Liu
Förderung
- Ministry of Public Security
- Open Project of the Key Laboratory of Drug Monitoring and Control, Ministry of Public Security, China
Zitieren
APA
Han, J., Zhang, Z., Liu, X., Yang, H., & Liu, L. (2025). Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models. Pharmaceutics, 17(2), 214. https://doi.org/10.3390/pharmaceutics17020214
Vancouver
Han J, Zhang Z, Liu X, Yang H, Liu L. Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models. Pharmaceutics. 2025;17(2):214. doi:10.3390/pharmaceutics17020214
BibTeX
@article{Han2025,
author = {Han, Jing and Zhang, Zexin and Liu, Xiaodong and Yang, Hanyu and Liu, Li},
title = {Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {2},
pages = {214},
doi = {10.3390/pharmaceutics17020214}
}
EUVIMED